Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2874.70Today’s High
2925.0052W low
1772.0052W High
2980.00Open Price
2874.70Prev. Close
2782.0000Volume
264554.00Value
764852069.40Fundamentals
Market Cap
97847.90
Price to Earnings
59.10
Price to Book Value
14.30
Dividend Yield
1.00
PE to Growth
1.70
Op Revenue TTM
10728.00
Net Profit TTM
1656.00
Cash From Operating Activity
3266.08
Return on Equity %
24.15
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
37.6
Week
64
Month
55.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2896.93
PIVOT
First Resistance
2919.17
Second Resistance
2947.23
Third Resistance
2969.47
First Support
2868.87
Second Support
2846.63
Third Support
2818.57
Relative Strength Index
63.76
Money Flow Index
54.11
MACD
29.37
MACD Signal
31.54
Average True Range
66.77
Average Directional Index
19.26
Rate of Change (21)
3.98
Rate of Change (125)
22.95
Commodity Channel Index
104.9
Williams %R
-39.7
BETA
1 Month
0.77
3 Month
0.28
1 Year
0.2
3 Year
-0.06
PRICE CHANGE ANALYSIS
↑ 4.31%
1 Week
Low
High
2757.9
2925
↑ 7.32%
1 Month
Low
High
2690.25
2980
↑ 13.93%
3 Months
Low
High
2505.3
2980
↑ 21.9%
6 Months
Low
High
2312
2980
↑ 53.97%
1 Year
Low
High
1772.05
2980
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2219.00 | 2112.00 | 2161.00 | 2132.00 | 1946.00 | 1872.00 | 1939.00 | 1962.00 | 1723.00 | 1625.00 | 1853.00 | |
| Operating Expenses Qtr | 1427.00 | 1422.00 | 1410.00 | 1384.00 | 1342.00 | 1272.00 | 1308.00 | 1268.00 | 1179.00 | 1161.00 | 1182.00 | |
| Operating Profit Qtr | 716.00 | 701.00 | 736.00 | 737.00 | 578.00 | 585.00 | 620.00 | 665.00 | 483.00 | 427.00 | 617.00 | |
| EBIDT Qtr Cr | 792.00 | 690.00 | 751.00 | 748.00 | 604.00 | 600.00 | 631.00 | 694.00 | 544.00 | 464.00 | 671.00 | |
| Depreciation Qtr | 195.00 | 191.00 | 192.00 | 183.00 | 182.00 | 156.00 | 156.00 | 149.00 | 147.00 | 152.00 | 153.00 | |
| Net Profit Qtr | 410.00 | 297.00 | 327.00 | 323.00 | 219.00 | 229.00 | 272.00 | 327.00 | 221.00 | 170.00 | 326.00 | |
| Basic EPS Qtr | 12.12 | 8.78 | 9.65 | 9.55 | 6.46 | 6.78 | 8.02 | 19.35 | 13.08 | 10.06 | 19.24 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 8624.26 | 7777.08 | 6946.49 | 6568.91 | 6405.37 | |
| Operating Expenses Annual Cr | 5643.60 | 5230.04 | 4641.56 | 4258.84 | 4251.45 | |
| Operating Profit Annual | 2889.30 | 2465.16 | 2100.76 | 2191.73 | 1916.99 | |
| Operating Profit Margin Annual % | 33.50 | 31.70 | 30.24 | 33.37 | 29.93 | |
| Total Expenses Annual Cr | 6707.69 | 6200.06 | 5480.28 | 5202.80 | 5288.60 | |
| EBIDT Annual Cr | 2980.66 | 2547.04 | 2304.93 | 2310.07 | 2153.92 | |
| EBIDT Annual margin % | 34.56 | 32.75 | 33.18 | 35.17 | 33.63 | |
| Depreciation | 761.05 | 672.34 | 602.43 | 609.84 | 606.66 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1357.08 | 1051.39 | 991.45 | 1137.85 | 938.51 | |
| Net Profit Annual | 1357.08 | 1051.39 | 991.45 | 1137.85 | 938.51 | |
| Basic EPS Annual | 40.10 | 31.07 | 58.59 | 67.24 | 55.46 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 6828.76 | 6455.96 | 6345.42 | 6030.10 | 5120.97 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 2559.23 | 3006.82 | 2383.78 | 3145.14 | 3376.02 | |
| Total Current Liabilities Annual Cr | 2988.60 | 3409.15 | 2423.36 | 2585.80 | 3387.48 | |
| Total Capital Plus Liabilities Annual Cr | 12376.59 | 12871.93 | 11152.56 | 11761.04 | 11884.47 | |
| Fixed Assets Annual | 8212.15 | 8669.78 | 6818.75 | 7329.35 | 7733.91 | |
| Total Non Current Assets Annual | 8635.53 | 8944.85 | 7092.51 | 7619.16 | 8065.21 | |
| Total Current Assets Annual | 3741.06 | 3927.08 | 4060.05 | 4141.88 | 3819.26 | |
| Total Assets Annual | 12376.59 | 12871.93 | 11152.56 | 11761.04 | 11884.47 | |
| Contingent Liabilities plus Commitments Annual Cr | 1395.40 | 1448.95 | 1296.42 | 1155.38 | 325.37 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 2893.10 | 2265.41 | 2140.10 | 1578.23 | 1579.90 | |
| Cash from Investing Activity Annual | -296.07 | -2384.07 | -159.70 | -316.28 | 269.43 | |
| Cash from Financing Annual Activity | -2577.57 | 80.74 | -1977.27 | -1586.54 | -1555.48 | |
| Net Cash Flow Annual | 19.46 | -37.92 | 3.13 | -324.59 | 293.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 201.76 | 190.75 | 374.94 | 356.30 | 302.59 | |
| ROE Annual % | 19.87 | 16.28 | 15.62 | 18.86 | 18.32 | |
| ROCE Annual % | 23.64 | 19.81 | 19.50 | 18.53 | 18.20 | |
| Total Debt to Total Equity Annual | 0.49 | 0.71 | 0.53 | 0.73 | 0.76 | |
| EBDIT Annual Margin % | 34.93 | 33.09 | 34.18 | 35.81 | 34.91 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2776.00 | 2699.00 | 2686.00 | 2625.00 | 2500.00 | 2481.00 | 2307.00 | 2377.00 | 2187.00 | 2156.00 | 2188.00 | |
| Operating Expenses Qtr | 1862.00 | 1863.00 | 1835.00 | 1800.00 | 1764.00 | 1767.00 | 1612.00 | 1635.00 | 1570.00 | 1570.00 | 1477.00 | |
| Operating Profit Qtr | 883.00 | 869.00 | 825.00 | 791.00 | 727.00 | 724.00 | 679.00 | 712.00 | 561.00 | 538.00 | 660.00 | |
| EBIDT Qtr Cr | 914.00 | 924.00 | 851.00 | 825.00 | 736.00 | 714.00 | 695.00 | 742.00 | 132.00 | 586.00 | 711.00 | |
| Depreciation Qtr | 203.00 | 213.00 | 201.00 | 191.00 | 196.00 | 193.00 | 163.00 | 155.00 | 162.00 | 167.00 | 168.00 | |
| Net Profit Qtr | 449.00 | 443.00 | 386.00 | 378.00 | 287.00 | 283.00 | 312.00 | 354.00 | -118.00 | 249.00 | 316.00 | |
| Basic EPS Qtr | 13.27 | 13.10 | 11.39 | 11.18 | 8.48 | 8.36 | 9.22 | 20.90 | -6.98 | 14.75 | 18.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 10785.75 | 9665.29 | 8704.60 | 8061.48 | 8060.61 | |
| Operating Expenses Annual Cr | 7360.19 | 6778.10 | 6076.77 | 5524.49 | 5768.95 | |
| Operating Profit Annual | 3367.65 | 2842.05 | 2431.27 | 2480.08 | 2170.36 | |
| Operating Profit Margin Annual % | 31.22 | 29.40 | 27.93 | 30.76 | 26.93 | |
| Total Expenses Annual Cr | 8522.02 | 7818.13 | 6993.99 | 6535.22 | 6874.04 | |
| EBIDT Annual Cr | 3425.56 | 2887.19 | 2627.83 | 2536.99 | 2291.66 | |
| EBIDT Annual margin % | 31.76 | 29.87 | 30.19 | 31.47 | 28.43 | |
| Depreciation | 808.27 | 706.59 | 662.16 | 657.79 | 654.38 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 | |
| Net Profit Annual | 1656.38 | 1245.23 | 777.18 | 1251.88 | 1024.72 | |
| Basic EPS Annual | 48.94 | 36.79 | 45.93 | 73.98 | 60.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 6856.15 | 6198.07 | 5952.95 | 5837.17 | 4823.22 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 2779.18 | 3366.48 | 2731.80 | 3345.86 | 3732.36 | |
| Total Current Liabilities Annual Cr | 5425.25 | 5447.30 | 4415.09 | 4891.62 | 5454.16 | |
| Total Capital Plus Liabilities Annual Cr | 15060.58 | 15011.85 | 13099.84 | 14074.65 | 14009.74 | |
| Fixed Assets Annual | 8160.59 | 8549.35 | 6792.99 | 7612.78 | 7902.96 | |
| Total Non Current Assets Annual | 9449.10 | 9682.67 | 7805.19 | 8551.43 | 9028.82 | |
| Total Current Assets Annual | 5611.48 | 5329.18 | 5294.65 | 5523.22 | 4980.92 | |
| Total Assets Annual | 15060.58 | 15011.85 | 13099.84 | 14074.65 | 14009.74 | |
| Contingent Liabilities plus Commitments Annual Cr | 575.06 | 619.01 | 505.35 | 324.34 | 374.59 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3266.08 | 2368.13 | 1802.99 | 2010.69 | 1392.91 | |
| Cash from Investing Activity Annual | -167.90 | -2415.31 | -196.63 | -449.42 | 198.61 | |
| Cash from Financing Annual Activity | -2779.64 | 77.36 | -1781.05 | -1656.13 | -1549.04 | |
| Net Cash Flow Annual | 318.54 | 30.18 | -174.69 | -94.86 | 42.48 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 202.57 | 183.13 | 351.75 | 344.90 | 284.99 | |
| ROE Annual % | 24.15 | 20.09 | 13.05 | 21.44 | 21.24 | |
| ROCE Annual % | 27.16 | 22.79 | 22.63 | 20.46 | 19.13 | |
| Total Debt to Total Equity Annual | 0.57 | 0.85 | 0.67 | 0.83 | 0.91 | |
| EBDIT Annual Margin % | 31.93 | 30.01 | 30.88 | 31.69 | 28.86 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE | 1.02 | 75070009 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| TORRENT INVESTMENTS PRIVATE LIMITED | 71.25 | 75070002 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE | 1.02 | 75070009 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Trusts | 1.13 | 75070019 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jun 21, 2024 | 6 | FINAL | Jun 21, 2024 | Equity Share |
| Feb 12, 2024 | 22 | INTERIM | Feb 12, 2024 | Equity Share |
| Jun 23, 2023 | 8 | FINAL | Jun 23, 2023 | Equity Share |
| Feb 03, 2023 | 14 | INTERIM | Feb 03, 2023 | Equity Share |
| Jun 03, 2022 | 15 | SPECIAL | Jun 06, 2022 | Equity Share |
| Jun 03, 2022 | 8 | FINAL | Jun 06, 2022 | Equity Share |
| Feb 02, 2022 | 25 | INTERIM | Feb 03, 2022 | Equity Share |
| Jun 17, 2021 | 15 | FINAL | Jun 18, 2021 | Equity Share |
| Feb 15, 2021 | 20 | INTERIM | Feb 16, 2021 | Equity Share |
| Mar 18, 2020 | 15 | SPECIAL | Mar 19, 2020 | Equity Share |
| Mar 18, 2020 | 17 | INTERIM | Mar 19, 2020 | Equity Share |
| Feb 03, 2020 | - | INTERIM | Feb 04, 2020 | Equity Share |
| Jun 13, 2019 | 4 | FINAL | Jun 14, 2019 | Equity Share |
| Feb 06, 2019 | 13 | INTERIM | Feb 07, 2019 | Equity Share |
| Jun 18, 2018 | 5 | FINAL | - | Equity Share |
| Feb 15, 2018 | 9 | INTERIM | Feb 19, 2018 | Equity Share |
| Jun 19, 2017 | 4 | FINAL | - | Equity Share |
| Feb 10, 2017 | 10 | INTERIM | Feb 13, 2017 | Equity Share |
| Mar 16, 2016 | 15 | INTERIM | Mar 17, 2016 | Equity Share |
| Feb 11, 2016 | 20 | INTERIM | Feb 12, 2016 | Equity Share |
| Jun 15, 2015 | 6.25 | FINAL | - | Equity Share |
| Feb 02, 2015 | 5 | INTERIM | Feb 03, 2015 | Equity Share |
| Jun 16, 2014 | 5 | FINAL | - | Equity Share |
| Jan 24, 2014 | 5 | INTERIM | Jan 27, 2014 | Equity Share |
| Jun 10, 2013 | 17 | FINAL | - | Equity Share |
| Feb 01, 2013 | 6 | INTERIM | Feb 04, 2013 | Equity Share |
| Jun 11, 2012 | 2.5 | FINAL | - | Equity Share |
| Jan 27, 2012 | 6 | INTERIM | Jan 30, 2012 | Equity Share |
| Jun 06, 2011 | 8 | FINAL | - | Equity Share |
| Jun 04, 2010 | 6 | FINAL | - | Equity Share |
| Jun 08, 2009 | 4 | FINAL | - | Equity Share |
| Jun 19, 2008 | 3.5 | FINAL | - | Equity Share |
| Mar 23, 2007 | 3 | INTERIM | Mar 26, 2007 | Equity Share |
| Jun 15, 2006 | 2.5 | FINAL | - | Equity Share |
| Jun 09, 2005 | 8 | FINAL | - | Equity Share |
| Jun 17, 2004 | 8 | FINAL | - | Equity Share |
| Jun 10, 2003 | 8 | FINAL | - | Equity Share |
| Jun 05, 2002 | - | FINAL | - | Equity Share |
| May 28, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Feb 20, 2006 | 10:5 | 2006-02-27 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 24, 2024 | Audited Results & Final Dividend | - |
| Feb 02, 2024 | Quarterly Results & Interim Dividend | - |
| Oct 23, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results & Final Dividend | - |
| Jan 25, 2023 | Quarterly Results & Interim Dividend | - |
| Oct 21, 2022 | Quarterly Results | - |
| Jul 29, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results, Dividend & Bonus issue | - |
| Jan 25, 2022 | Quarterly Results & Interim Dividend | - |
| Oct 26, 2021 | Quarterly Results | - |
| Jul 27, 2021 | Quarterly Results | - |
| May 18, 2021 | Audited Results & Final Dividend | Inter alia, Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) etc. |
| Feb 08, 2021 | Quarterly Results & Interim Dividend | - |
| Oct 26, 2020 | Quarterly Results | - |
| Jul 30, 2020 | Quarterly Results | - |
| May 26, 2020 | Audited Results | - |
| Mar 11, 2020 | Interim Dividend | - |
| Jan 27, 2020 | Quarterly Results & Interim Dividend | inter alia, Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or any other modes |
| Oct 23, 2019 | Quarterly Results | - |
| Jul 23, 2019 | Quarterly Results | - |
| May 20, 2019 | Audited Results & Final Dividend | - |
| Jan 30, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 03, 2018 | Quarterly Results | - |
| Aug 02, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Final Dividend | - |
| Feb 08, 2018 | Quarterly Results & Interim Dividend | - |
| Jan 25, 2018 | Others | - |
| Nov 03, 2017 | Quarterly Results | - |
| Jul 31, 2017 | Quarterly Results | - |
| May 26, 2017 | Audited Results & Final Dividend | - |
| Feb 03, 2017 | Quarterly Results & Interim Dividend | - |
| Oct 26, 2016 | Quarterly Results | - |
| Jul 27, 2016 | Quarterly Results | - |
| May 23, 2016 | Others | The Board did not recommend distribution of any further dividend. |
| Mar 23, 2016 | Others | Inter-alia the proposal for raising of funds by way of: a) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placements (QIP) and/ or Depository Receipts. |
| Mar 09, 2016 | Second Interim Dividend | - |
| Feb 04, 2016 | Quarterly Results & Interim Dividend | - |
| Oct 29, 2015 | Quarterly Results | - |
| Jul 27, 2015 | Quarterly Results | - |
| May 15, 2015 | Audited Results & Final Dividend | - |
| Jan 28, 2015 | Quarterly Results & Interim Dividend | - |
| Nov 05, 2014 | Quarterly Results | - |
| Jul 30, 2014 | Quarterly Results | - |
| May 09, 2014 | Audited Results & Final Dividend | - |
| Jan 21, 2014 | Quarterly Results & Interim Dividend | - |
| Oct 30, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results & Final Dividend | - |
| Jan 29, 2013 | Quarterly Results & Interim Dividend | - |
| Oct 26, 2012 | Quarterly Results | - |
| Jul 23, 2012 | Quarterly Results | - |
| May 18, 2012 | Audited Results & Final Dividend | - |
| Jan 23, 2012 | Quarterly Results & Interim Dividend | - |
| Oct 18, 2011 | Quarterly Results | - |
| Jul 30, 2011 | Quarterly Results | - |
| May 28, 2011 | Audited Results & Dividend | - |
| Jan 19, 2011 | Quarterly Results | - |
| Oct 23, 2010 | Quarterly Results | - |
| Jul 30, 2010 | Quarterly Results | - |
| May 06, 2010 | Audited Results & Dividend | - |
| Jan 27, 2010 | Quarterly Results | - |
| Oct 31, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results | - |
| May 15, 2009 | Audited Results & Dividend | - |
| Jan 28, 2009 | Quarterly Results | - |
| Oct 24, 2008 | Quarterly Results | - |
| May 06, 2008 | Audited Results & Dividend | - |
| Jan 31, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Jul 31, 2007 | Quarterly Results | - |
| May 23, 2007 | Audited Results | - |
| Mar 17, 2007 | Interim Dividend | - |
| Jan 24, 2007 | Quarterly Results | - |
| Oct 28, 2006 | Quarterly Results | - |
| Jul 21, 2006 | Quarterly Results | - |
| May 23, 2006 | Accounts & Dividend | - |
| Jan 25, 2006 | Quarterly Results | - |
| Dec 15, 2005 | Stock Split & Bonus Issue | - |
| Oct 26, 2005 | Quarterly Results | - |
| Jul 26, 2005 | Quarterly Results | - |
| May 13, 2005 | Dividend & Accounts | - |
| Jan 21, 2005 | Quarterly Results | - |
| Aug 17, 2004 | Quarterly Results | - |
| Jun 10, 2004 | Dividend & Accounts | - |
| Jan 27, 2004 | Quarterly Results | - |
| Oct 23, 2003 | Quarterly Results | - |
| Jul 31, 2003 | Quarterly Results | - |
| Jun 05, 2003 | Accounts | (Revised) |
| Jan 23, 2003 | Quarterly Results | - |
| Oct 23, 2002 | Accounts | - |
| Jul 22, 2002 | Quarterly Results | - |
| May 13, 2002 | Accounts | - |
| Mar 09, 2002 | Interim Dividend | - |
| Jan 24, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Quarterly Results | - |
| Jul 23, 2001 | Quarterly Results | - |
| May 25, 2001 | Dividend & Accounts | - |
| Jan 24, 2001 | Quarterly Results | - |
| Oct 19, 2000 | Quarterly Results | - |
| Jul 24, 2000 | Quarterly Results | - |
| May 10, 2000 | Accounts & Final Dividend | - |
| Mar 27, 2000 | Interim Dividend | - |
| Jan 24, 2000 | Quarterly Results | - |
| Jul 23, 1999 | Quarterly Results | - |
| May 26, 1999 | Accounts | - |
| Jan 22, 1999 | Quarterly Results | - |
| Oct 29, 1998 | Quarterly Results | - |
| Jul 27, 1998 | Quaterly Results | - |
| Jun 20, 1998 | Accounts & Dividend | - |
| Nov 21, 1997 | Half Yearly Results | - |
| Jun 21, 1997 | Accounts & Dividend. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jul 08, 2022 | 1:1 | 2022-07-11 |
| Jul 23, 2013 | 1:1 | 2013-07-24 |
| Feb 20, 2006 | 1:1 | 2006-02-27 |
05 Jul 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Consider And Approve The Audited Financial Results On Standalone Basis And Unaudited Financial Results (With Limited Review) On Consolidated Basis Of The Company For The Quarter Ended On 30-Jun-24.
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday, 23-Jul-24, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-24.
03 Jul 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
03 Jul 2024
Torrent Pharma - Focus On Branded Generics, Profitability: HDFC Securities
Its two plants Dahej and Bileshwarpura (oral onco) received the U.S. FDA clearance, and it expects launch momentum to start from Q1 FY25
01 Jul 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cuttings in connection with the 51st Annual General Meeting and E-Voting Procedure.
29 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of The Annual Report For The FY 2023-24 And The Notice Convening 51St Annual General Meeting Of The Company.
Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company
29 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Business Responsibility and Sustainability Reporting (BRSR)
Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company
29 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report.
Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means
28 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
25 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Intimation of the 51st Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means ("VC / OAVM") facility
21 Jun 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
